We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-20.16%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$25.2M
Cap. Flow
+$287M
Cap. Flow %
23.51%
Top 10 Hldgs %
5.22%
Holding
1,483
New
378
Increased
381
Reduced
313
Closed
382

Top Buys

Rank Stock Value
1
ASAN icon
Asana
ASAN
+$8.41M
2
MRVL icon
Marvell Technology
MRVL
+$8.25M
3
GFS icon
GlobalFoundries
GFS
+$7.98M
4
NFLX icon
Netflix
NFLX
+$7.87M
5
ZBRA icon
Zebra Technologies
ZBRA
+$7.48M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$6.39M
2
TTD icon
Trade Desk
TTD
+$6.28M
3
XYL icon
Xylem
XYL
+$6.22M
4
GILD icon
Gilead Sciences
GILD
+$6.21M
5
UAA icon
Under Armour
UAA
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 21.57%
2 Healthcare 15.01%
3 Industrials 12.49%
4 Financials 12.17%
5 Consumer Discretionary 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBT
1026
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$93K 0.01%
+16,320
New +$107K
BRY
1027
DELISTED
Berry Corp
BRY
$92K 0.01%
12,054
-6,719
-36% -$71K
IVC
1028
DELISTED
Invacare Corporation
IVC
$91K 0.01%
71,168
– –
MRSN
1029
DELISTED
Mersana Therapeutics
MRSN
$88K 0.01%
762
-4,767
-86% -$448K
ETNB
1030
DELISTED
89bio
ETNB
$86K 0.01%
26,667
+10,234
+62% +$30.9K
VIA
1031
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$85K 0.01%
2,227
+47
+2% +$1.85K
STKS icon
1032
The ONE Group
STKS
$56.2M
$83K 0.01%
11,297
-305
-3% -$2.78K
CRNT icon
1033
Ceragon Networks
CRNT
$197M
$81K 0.01%
31,606
-43
-0.1% -$82
PDSB icon
1034
PDS Biotechnology
PDSB
$38.4M
$81K 0.01%
+22,085
New +$105K
MRAM icon
1035
Everspin Technologies
MRAM
$341M
$79K 0.01%
15,071
-7,376
-33% -$47.5K
VTGN icon
1036
VistaGen Therapeutics
VTGN
$9.89M
$78K 0.01%
2,965
– –
MAGN
1037
Magnera Corp
MAGN
$472M
$78K 0.01%
+870
New +$104K
KLR
1038
DELISTED
Kaleyra, Inc.
KLR
$78K 0.01%
10,877
-334
-3% -$4.9K
GPGI
1039
GPGI Inc
GPGI
$3.83B
$77K 0.01%
+17,772
New +$101K
AMTX icon
1040
Aemetis
AMTX
$106M
$75K 0.01%
+15,370
New +$134K
QMCO icon
1041
Quantum Corp
QMCO
$419M
$75K 0.01%
5,294
-1,965
-27% -$74.4K
VRCA icon
1042
Verrica Pharmaceuticals
VRCA
$89.7M
$74K 0.01%
+3,869
New +$194K
PLXP
1043
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$71K 0.01%
29,301
+18,515
+172% +$51.4K
ADMA icon
1044
ADMA Biologics
ADMA
$1.96B
$70K 0.01%
+35,119
New +$69.1K
OMGA
1045
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$70K 0.01%
+18,323
New +$68.2K
BNED icon
1046
Barnes & Noble Education
BNED
$431M
$68K 0.01%
231
+56
+32% +$16.2K
KOS icon
1047
Kosmos Energy
KOS
$1.6B
$66K 0.01%
10,680
-132,205
-93% -$954K
SRAX
1048
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$65K 0.01%
81,383
– –
BOLT icon
1049
Bolt Biotherapeutics
BOLT
$7.67M
$63K 0.01%
1,541
+252
+20% +$9.78K
GTBP icon
1050
GT Biopharma
GTBP
$10.6M
$63K 0.01%
700
+31
+5% +$2.35K
40 41
42
43 44

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return

Occudo Quantitative Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Occudo Quantitative Strategies held 1,483 positions worth $1.22B, up 2.1% from $1.19B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Occudo Quantitative Strategies deployed $287M of net new capital in Q2 2022, opening 378 new positions and adding to 381 existing holdings. Its largest new stake was Marvell Technology: 145,519 shares worth $6.33M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $5.12M trimmed.

  • Occudo Quantitative Strategies's largest Q2 2022 buy was Marvell Technology: 145,519 shares worth $6.33M.
  • Occudo Quantitative Strategies added most to Asana in Q2 2022, an estimated $8.41M increase.
  • Occudo Quantitative Strategies's biggest Q2 2022 reduction was Sherwin-Williams, cutting an estimated $5.12M.
  • Occudo Quantitative Strategies fully exited 3M in Q2 2022, selling an estimated $6.39M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.2% of its $1.22B portfolio in Q2 2022.
  • Occudo Quantitative Strategies opened 378 new positions and closed 382 in Q2 2022.
  • Occudo Quantitative Strategies's portfolio value rose 2.1% quarter-over-quarter to $1.22B.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.